Paras Healthcare has raised Rs 652.5 crore from anchor investors, attracting broad participation from leading domestic and ...

It is being launched through SynBioME – the IIT Madras-TICEL Biofoundry, which focuses on advancing biotechnology research, ...

The Central Drugs Standard Control Organisation (CDSCO), under the Drug Controller General of India (DCGI), has granted ...

In August 2025, Suramrit continued his research at ReeLABs Research Centre in Mumbai under Dr Abhijit Bhopadikar, working with human blood samples for approximately 20 hours a week. The research ...

Indy Hand is Motorica’s myoelectric forearm prosthesis designed for people with upper-limb amputations and congenital limb differences. The model is actively sold in Russia and international markets.

Hyderabad-based Mapmygenome has announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in ...

Immuna Therapeutics AG inks $3 M partnership with NIMS University Rajasthan for advanced CAR-T cancer therapy access in India ...

The National Medical Commission (NMC) has recently announced a move enabling Registered Medical Practitioners (RMPs) to ...

India’s pharmaceutical industry is globally recognised for its capabilities in research and manufacturing and for its skilled labour. The country’s attractiveness as a destination for Global ...

India is projected to require an additional 2.6 billion sq. ft. of healthcare real estate by 2035, driven by the need for ...

AstraZeneca Pharma India has inaugurated its new corporate office in Mumbai, marking an extension of company’s presence in ...

Investors can help shape the next phase of rehabilitation care by backing models that combine clinical credibility with ...